Envoy Medical (COCH) Total Non-Current Liabilities (2021 - 2026)

Envoy Medical (COCH) has 6 years of Total Non-Current Liabilities data on file, last reported at $19.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 41.4% year-over-year to $19.2 million; the trailing twelve-month figure through Mar 2026 stood at $19.2 million (down 41.4% YoY), and the FY2025 full-year result was $20.3 million, down 32.13% from the prior year.
• Total Non-Current Liabilities fell to $19.2 million in Q1 2026, from $20.3 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $38.9 million in Q2 2025 to a low of $8.1 million in Q4 2023.
• A 5-year average of $21.8 million and a median of $19.9 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities plunged 78.97% in 2023 and jumped 268.14% in 2024, its largest moves.
• Tracing COCH's Total Non-Current Liabilities over 5 years: stood at $38.6 million in 2022, then sank by 78.97% to $8.1 million in 2023, then jumped by 268.14% to $29.9 million in 2024, then slumped by 32.13% to $20.3 million in 2025, then declined by 5.2% to $19.2 million in 2026.
• Business Quant data shows COCH's Total Non-Current Liabilities at $19.2 million in Q1 2026, $20.3 million in Q4 2025, and $15.7 million in Q3 2025.